Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Reicherz

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Reviews in Allergy & Immunology|June 11, 2022
Correlates of Protection Against Respiratory Syncytial Virus Infection in InfancyBahaa Abu-Raya, Frederic Reicherz, Pascal M Lavoie
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 27, 2021
Potential resurgence of respiratory syncytial virus in CanadaPascal M Lavoie, Frederic Reicherz, Alfonso Solimano, et al.
Vaccine|May 22, 2022
Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measuresFrederic Reicherz, Liam Golding, Pascal M Lavoie, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 17, 2021
Pascal M Lavoie, Frederic Reicherz, Alfonso Solimano, et al.
Eclinicalmedicine|July 24, 2023
Why has the epidemiology of RSV changed during the COVID-19 pandemic?Bahaa Abu-Raya, Marina Viñeta Paramo, Frederic Reicherz, et al.
Vaccine|May 26, 2024
Bordetella pertussis infection following relaxation of COVID-19 non-pharmaceutical interventions in 2021-2023 in Vancouver metropolitan area, British Columbia, CanadaFrederic Reicherz, Sirui Li, Allison A Watts, et al.
Journal of the Pediatric Infectious Diseases Society|January 27, 2024
Efficacy of Palivizumab Immunoprophylaxis for Reducing Severe RSV Outcomes in Children with Immunodeficiencies: A Systematic ReviewFrederic Reicherz, Bahaa Abu-Raya, Omolabake Akinseye, et al.
Gut|November 24, 2021
Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapyZahra Jama Shire, Frederic Reicherz, Sally Lawrence, et al.
Journal of the Pediatric Infectious Diseases Society|November 10, 2023
Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation MeasuresBahaa Abu-Raya, Frederic Reicherz, Christina Michalski, et al.
The Journal of Infectious Diseases|March 18, 2025
Recovery of Antibody Immunity After a Resurgence of Respiratory Syncytial Virus InfectionsFrederic Reicherz, Marina Viñeta Paramo, Jeffrey N Bone, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Reviews in Allergy & Immunology|June 11, 2022
Correlates of Protection Against Respiratory Syncytial Virus Infection in InfancyBahaa Abu-Raya, Frederic Reicherz, Pascal M Lavoie
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 27, 2021
Potential resurgence of respiratory syncytial virus in CanadaPascal M Lavoie, Frederic Reicherz, Alfonso Solimano, et al.
Vaccine|May 22, 2022
Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measuresFrederic Reicherz, Liam Golding, Pascal M Lavoie, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 17, 2021
Pascal M Lavoie, Frederic Reicherz, Alfonso Solimano, et al.
Eclinicalmedicine|July 24, 2023
Why has the epidemiology of RSV changed during the COVID-19 pandemic?Bahaa Abu-Raya, Marina Viñeta Paramo, Frederic Reicherz, et al.
Vaccine|May 26, 2024
Bordetella pertussis infection following relaxation of COVID-19 non-pharmaceutical interventions in 2021-2023 in Vancouver metropolitan area, British Columbia, CanadaFrederic Reicherz, Sirui Li, Allison A Watts, et al.
Journal of the Pediatric Infectious Diseases Society|January 27, 2024
Efficacy of Palivizumab Immunoprophylaxis for Reducing Severe RSV Outcomes in Children with Immunodeficiencies: A Systematic ReviewFrederic Reicherz, Bahaa Abu-Raya, Omolabake Akinseye, et al.
Gut|November 24, 2021
Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapyZahra Jama Shire, Frederic Reicherz, Sally Lawrence, et al.
Journal of the Pediatric Infectious Diseases Society|November 10, 2023
Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation MeasuresBahaa Abu-Raya, Frederic Reicherz, Christina Michalski, et al.
The Journal of Infectious Diseases|March 18, 2025
Recovery of Antibody Immunity After a Resurgence of Respiratory Syncytial Virus InfectionsFrederic Reicherz, Marina Viñeta Paramo, Jeffrey N Bone, et al.
Pageof 2